CA1177451A - Dispositif actionne par le souffle pour administrer des medicaments en poudre - Google Patents

Info

Publication number

CA1177451A

CA1177451A CA000375893A CA375893A CA1177451A CA 1177451 A CA1177451 A CA 1177451A CA 000375893 A CA000375893 A CA 000375893A CA 375893 A CA375893 A CA 375893A CA 1177451 A CA1177451 A CA 1177451A

Authority

CA

Canada

Prior art keywords

capsule

carousel

chamber

base

lid

Prior art date

1981-04-22

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Expired

Links

• Espacenet
• Global Dossier
• CIPO
• Discuss

• 239000003814 drug Substances 0.000 title claims abstract description 67
• 239000002775 capsule Substances 0.000 claims abstract description 165
• 239000000843 powder Substances 0.000 claims abstract description 25
• 230000008093 supporting effect Effects 0.000 claims abstract description 9
• 239000002245 particle Substances 0.000 claims abstract description 8
• 230000006854 communication Effects 0.000 claims abstract description 3
• 238000004891 communication Methods 0.000 claims abstract description 3
• 239000000306 component Substances 0.000 claims description 70
• 239000000463 material Substances 0.000 claims description 4
• 238000000926 separation method Methods 0.000 claims description 3
• 229940079593 drug Drugs 0.000 description 11
• 230000007246 mechanism Effects 0.000 description 10
• 210000004072 lung Anatomy 0.000 description 8
• 239000000203 mixture Substances 0.000 description 7
• 238000012360 testing method Methods 0.000 description 5
• GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 4
• GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 4
• 230000000881 depressing effect Effects 0.000 description 4
• 230000000694 effects Effects 0.000 description 4
• 238000003780 insertion Methods 0.000 description 4
• 230000037431 insertion Effects 0.000 description 4
• 229960001375 lactose Drugs 0.000 description 4
• 239000008101 lactose Substances 0.000 description 4
• 230000003068 static effect Effects 0.000 description 4
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
• 230000009471 action Effects 0.000 description 3
• 208000006673 asthma Diseases 0.000 description 3
• 210000003800 pharynx Anatomy 0.000 description 3
• 239000003380 propellant Substances 0.000 description 3
• QPYZEEKXUYXZBK-KATIXKQHSA-N 4-[(s)-hydroxy-[(2r)-piperidin-2-yl]methyl]benzene-1,2-diol;hydrobromide Chemical compound Br.C([C@@H]1[C@@H](O)C=2C=C(O)C(O)=CC=2)CCCN1 QPYZEEKXUYXZBK-KATIXKQHSA-N 0.000 description 2
• ZOLBALGTFCCTJF-UHFFFAOYSA-N 4-[1-hydroxy-2-(propan-2-ylamino)ethyl]benzene-1,2-diol;sulfuric acid Chemical compound OS(O)(=O)=O.CC(C)NCC(O)C1=CC=C(O)C(O)=C1.CC(C)NCC(O)C1=CC=C(O)C(O)=C1 ZOLBALGTFCCTJF-UHFFFAOYSA-N 0.000 description 2
• 229940124630 bronchodilator Drugs 0.000 description 2
• 238000010276 construction Methods 0.000 description 2
• 230000000994 depressogenic effect Effects 0.000 description 2
• 238000009826 distribution Methods 0.000 description 2
• 239000011888 foil Substances 0.000 description 2
• 239000007789 gas Substances 0.000 description 2
• 230000004048 modification Effects 0.000 description 2
• 238000012986 modification Methods 0.000 description 2
• 239000000902 placebo Substances 0.000 description 2
• 229940068196 placebo Drugs 0.000 description 2
• 239000004033 plastic Substances 0.000 description 2
• 229920003023 plastic Polymers 0.000 description 2
• 230000009325 pulmonary function Effects 0.000 description 2
• 229960001953 rimiterol hydrobromide Drugs 0.000 description 2
• 239000004743 Polypropylene Substances 0.000 description 1
• 239000000443 aerosol Substances 0.000 description 1
• 229910052790 beryllium Inorganic materials 0.000 description 1
• 238000007664 blowing Methods 0.000 description 1
• 230000003182 bronchodilatating effect Effects 0.000 description 1
• 230000008859 change Effects 0.000 description 1
• 238000010586 diagram Methods 0.000 description 1
• 239000006185 dispersion Substances 0.000 description 1
• 238000009472 formulation Methods 0.000 description 1
• 230000002452 interceptive effect Effects 0.000 description 1
• 238000000465 moulding Methods 0.000 description 1
• 238000005192 partition Methods 0.000 description 1
• -1 polypropylene Polymers 0.000 description 1
• 229920001155 polypropylene Polymers 0.000 description 1
• 238000002360 preparation method Methods 0.000 description 1
• 230000002685 pulmonary effect Effects 0.000 description 1
• 230000000717 retained effect Effects 0.000 description 1
• 230000001360 synchronised effect Effects 0.000 description 1
• 238000012546 transfer Methods 0.000 description 1